Results 171 to 180 of about 1,656,075 (396)

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT‐MI

ESC Heart Failure, EarlyView.
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti, Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington, Michaela Mattheus, Johann Bauersachs, Antoni Bayes‐Genis, Shaun G. Goodman, Tomasz Gasior, James L. Januzzi, Renato D. Lopes, Piotr Ponikowski, Xavier Rossello, Morten Schou, Peter van der Meer, Dragos Vinereanu, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker   +23 more
wiley   +1 more source

Coronary Angiographic Profile in Patients with Conduction System Disorder Requiring Permanent Cardiac Pacing

, 1970
AAS Majumder, MA Ali, MTBA Rashid
openalex   +2 more sources

Cardiac pacing in patients with Fontan circulation: Further considerations

, 2022
Kenan Yalta, Muhammet Gürdoğan, Tülin Yalta   +2 more
openalex   +2 more sources

Leadless cardiac ventricular pacing using helix fixation: Step‐by‐step guide to implantation [PDF]

, 2022
Balint Laczay, Jose Aguilera, Daniel J. Cantillon   +2 more
openalex   +1 more source

Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials

ESC Heart Failure, EarlyView.
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz, Francesco Fioretti, Sara Ladak, Mohammed Obaidan, Javed Butler, Aamir Hameed   +5 more
wiley   +1 more source

Clinical Updates in Cardiac Pacing-The Future Is Bright. [PDF]

J Clin Med, 2022
Vandenberk B, Ballantyne BA, Chew DS.
europepmc   +1 more source

Rapid Ventricular Pacing for Landing Zone Precision During Thoracic Endovascular Aortic Arch Repair: A Case Series. [PDF]

, 2017
Bokoch, Michael P, Hiramoto, Jade S, Lobo, Errol P, Shalabi, Ahmed   +3 more
core   +1 more source

Takotsubo cardiomyopathy during armed conflict: A case series

ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha, Artyom Star, Gili Givaty, Michael Shilo, Michael Friger, Vladimir Chitoroga, Hezzy Shmueli, Yigal Abramowitz, Elad Asher, Jamal Jafari, Vladimir Shlyakhover, Doron Zahger, Moti Haim, Chaim Yosefy   +13 more
wiley   +1 more source

The emerging role of Nrf2 in heart failure: From cardioprotection to therapeutic approaches

ESC Heart Failure, EarlyView.
Nrf2 signalling is impaired in heart failure, contributing to oxidative stress, mitochondrial dysfunction, and ferroptosis, which drive neurohormonal activation, inflammation, and ischaemia‐reperfusion injury. This loss of Nrf2 activity exacerbates hypertension, diabetic cardiomyopathy, and cardiotoxicity, accelerating progression to overt heart ...
Emiliano Fiori, Sergio Davinelli, Armando Ferrera, Alessandro Medoro, Carlo Barsali, Allegra Battistoni, Maurizio Volterrani, Massimo Volpe, Luciano Saso, Speranza Rubattu   +9 more
wiley   +1 more source

19-06: Clinical Outcomes at One Year Follow UP in cardiac resynchronization therapy with Acute Optimization of Left Ventricular Pacing Site and Multipoint Pacing [PDF]

, 2016
Francesco Zanon, Lina Marcantoni, Gianni Pastore, Enrico Baracca, Roberto Floris, Daniela Lanza, Silvio Aggio, Luca Conte, Claudio Picariello, Franco Noventa, Loris Roncon, Frits Prinzen   +11 more
openalex   +1 more source